{"prompt": "['CONFIDENTIAL', 'PROTOCOL SUMMARY', 'Title:', 'E-FIT TRIAL: ELECTRIC FIELD NAVIGATED 1Hz RTMS FOR', 'POST-STROKE MOTOR RECOVERY TRIAL.', 'A', 'PROSPECTIVE, MULTI-CENTER, RANDOMIZED, SHAM-', 'CONTROLLED TRIAL TO DETERMINE THE THERAPEUTIC EFFECTS', 'OF NAVIGATION GUIDED 1 Hz RTMS ADMINISTERED TO THE', 'CONTRALESIONAL HEMISPHERE AS ADJUVANT TO TASK-', 'ORIENTED REHABILITATION IN PATIENTS WITH ISCHEMIC STROKE', 'Design:', 'Prospective, double-blinded, randomized, sham-controlled multi-center trial.', 'Purpose:', 'To determine whether navigation guided rTMS targeted to the non-lesioned', 'hemisphere in patients with stroke has a beneficial effect on the results of', 'subsequently performed task-oriented motor rehabilitation of the hand.', 'A total of 5 centers in the USA', 'Study locations:', '-', 'Central site : Brain Innovation Center, AbilityLab, Chicago, IL', '-', 'Other participating centers:', 'Burke Rehabilitation Hospital', 'White Plains, New York', 'University of Cincinnati', 'Cincinnati, OH', 'Rancho Los Amigos National Rehabilitation', 'Center Downey, CA', 'Spaulding Rehabilitation Hospital', 'Boston, MA', 'Principal', 'Richard L. Harvey, MD Medical Director, Center for Stroke Rehabilitation,', 'Investigator:', 'The Rehabilitation Institute of Chicago, Northwestern University Feinberg', 'School of Medicine.', 'Enrollment:', '60 patients with sub-acute ischemic stroke', 'Study duration: 18 months', 'Subject', 'Patients with subacute stroke (3-12 months after the insult) aged 18 and over', 'Population:', 'with no other brain abnormalities.', 'Page 6 of 57']['CONFIDENTIAL', 'Primary', 'Determination of whether 1Hz NBS guided rTMS targeting the motor', 'Assessment', 'representation areas of hand muscles on the non-lesioned brain hemisphere', 'has a beneficial effect on the motor recovery of the corresponding stroke-', 'affected muscles when combined with standardized task-oriented motor', 'rehabilitation.', 'Primary outcome measure: Upper-extremity Fugl-Meyer score.', 'The beneficial effect of 1Hz NBS guided rTMS will be established if', 'a', 'statistically signicantly greater proportion of patients receiving NBS-rTMS', 'attain clinically important improvement in the primary outcome measure than', 'patients receiving sham-rTMS between baseline and 6 months post-treatment.', 'Minimal clinically important improvement is defined as an increase of 5 points', 'on the upper extremity Fugl-Meyer score [Page SJ, et al. 2012].', 'Secondary', '1. Secondary outcome measures for the study are:', 'Assessments', 'and', 'Arm-Research Action Test (ARAT)', 'Enppoints:', 'NIH Stroke Scale (NIHSS)', 'Quality of life assessment: EQ-5D questionnaire.', 'The changes on these scales between baseline and 6 months post-treatment', 'will be determined for both therapy groups and the groups compared to each', 'other.', '2. Safety endpoint', 'To assess safety of study device use, all Serious Adverse Events and', 'Unanticipated Adverse Device Events and Device Related Adverse', 'Events will be recorded and compared between therapy groups.', 'ABBREVIATIONS', 'APB', 'Abductor Pollicis Brevis', 'CRO', 'Clinical Research Organization', 'Page 7 of 57']['CONFIDENTIAL', 'EDC', 'Extensor Digitorum Communis', 'EMG', 'Electromyography', 'FDA', 'Food and Drug Administration', 'fMRI', 'Functional Magnetic Resonance Imaging', 'IRB', 'Institutional Review Board', 'MEP', 'Motor Evoked Potential', 'MRI', 'Magnetic Resonance Imaging', 'MT', 'Motor Threshold', 'NBS', 'Navigated Brain Stimulation', 'NBT', 'Navigated Brain Therapy', 'rTMS', 'Repetitive Transcranial Magnetic Stimulation', 'SAE', 'Serious Adverse Events', 'SD', 'Standard Deviation', 'TMS', 'Transcranial Magnetic Stimulation', 'Page 8 of 57']\n\n###\n\n", "completion": "END"}